What is Soligenix Inc.?
, a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.50M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.